FDA Inspection Report Cites Theranos Used “Uncleared Medical Device” | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

FDA Inspection Report Cites Theranos Used “Uncleared Medical Device”

October 27, 2015
by Heather Landi
| Reprints

The U.S. Food and Drug Administration found flaws in the process that medical testing company Theranos used to validate its blood-testing products, according to inspections reports the agency posted to its website.

The FDA has posted two inspection reports to its website based on inspections conducted August 25th through September 16th at Theranos’ Palo Alto, Calif. and Newark, N.J. facilities.

Healthcare Informatics obtained access to the FDA inspection reports from a link in an online article posted by Bloomberg Business.

Theranos is a biomedical startup that has developed technology for a blood testing device that requires only a finger prick blood sample for lab tests, as opposed to patients’ getting their blood drawn via a needle in a doctor’s office or lab, which often requires vials of blood.

One inspection report, which is heavily redacted, states that the “design validation did not ensure the device conforms to defined user needs and intended uses” and that the “design was not validated under actual or simulated use conditions.”

In a second inspection report for Theranos, Inc., the FDA states that the company’s “capillary tube nanotainer (CTN), a blood specimen collection device,” which refers to the small vials the company uses for the finger stick blood sample, is a “Class II medical device,” yet Theranos listed the device as a “Class I exempt medical device.”

The inspection report states, “You are currently shipping this uncleared medical device in interstate commerce, between California, Arizona and Pennsylvania.”

According to the Bloomberg Business article, the company said it had “addressed and corrected all the observations at the time of, or within a week of, the inspection.”

While Theranos lists about 200 tests on its online menu, the company said this month that it is using its new technology on only one test.

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Dignity Health, UCSF Health Partner to Improve the Digital Patient Experience

Dignity Health and UCSF Health are collaborating to develop a digital engagement platform that officials believe will provide information and access to patients when and where they need it as they navigate primary and preventive care, as well as more acute or specialty care.

Report: Digital Health VC Funding Surges to Record $4.9 Billion in 2018

Global venture capital funding for digital health companies in the first half of 2018 was 22 percent higher year-over-year (YoY) with a record $4.9 billion raised in 383 deals compared to the $4 billion in 359 deals in the same time period last year, according to Mercom Capital Group’s latest report.

ONC Roundup: Senior Leadership Changes Spark Questions

The Office of the National Coordinator for Health IT (ONC) has continued to experience changes within its upper leadership, leading some folks to again ponder what the health IT agency’s role will be moving forward.

Media Report: Walmart Hires Former Humana Executive to Run Health Unit

Reigniting speculation that Walmart and insurer Humana are exploring ways to forge a closer partnership, Walmart Inc. has hired a Humana veteran to run its health care business, according to a report from Bloomberg.

Value-Based Care Shift Has Halted, Study Finds

A new study of 451 physicians and health plan executives suggests that progress toward value-based care has stalled. In fact, it may have even taken a step backward over the past year, the research revealed.

Study: EHRs Tied with Lower Hospital Mortality, But Only After Systems Have Matured

Over the past decade, there has been significant national investment in electronic health record (EHR) systems at U.S. hospitals, which was expected to result in improved quality and efficiency of care. However, evidence linking EHR adoption to better care is mixed, according to medical researchers.